To include your compound in the COVID-19 Resource Center, submit it here.

HKSE proposes to expand listing eligibility for biotechs

Hong Kong Exchanges and Clearing Ltd. (HKEX) said Friday that it will amend its listing rules to allow pre-revenue biotechs and companies from emerging and innovative sectors with weighted voting rights (WVR) structures to list on

Read the full 364 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers